Active ingredientAmprenavirCat. No. P-A146-001CAS 161814-49-9Family · Pharmaceutical analytical standards
Amprenavir
An inhibitor of HIV protease, an enzyme essential for the maturation of the virus; patented in 1992, it was approved in the United States in 1999 for the treatment of HIV infection. This family brings together the active ingredient, labelled standards and other impurities.
Did you know?Its production stopped at the end of 2004, but the molecule lives on in the prodrug fosamprenavir, which the body converts into amprenavir itself.
Go to the active ingredient →Active ingredientAmprenavirCat. No. P-A146-001CAS 161814-49-9
Isotopically labelledAmprenavir-d4Cat. No. P-A146-002CAS 2738376-78-6
Impurity(S)-4-chlorobutane-1,3-diolCat. No. P-A146-003CAS 139013-68-6No product matches your search.
Need a molecule you cannot find?
Custom synthesis of impurities, metabolites and labelled compounds, with the same characterisation level.